PHT Announces $34 Million in Bookings YTD with Fourth Consecutive Record-Breaking Fiscal Quarter
World leader in ePRO solutions on track for fifth straight year of double-digit revenue growth
BOSTON, Mass. – November 7, 2007 – PHT Corporation, the world leader in electronic patient reported outcome (ePRO) solutions, today reported year to date bookings of $34 million through the third quarter of 2007. The company was profitable in 2006 and will continue to be profitable in 2007.
Highlights of PHT’s third fiscal quarter:
- Awarded 24 new trials from 12 leading biopharmaceutical companies using PHT’s LogPad(R) and StudyPad(R) Systems, thus bringing the total number of trials worldwide to more than 330 – by far the most in the eDiary industry
- Selected by a top five pharmaceutical company as its sole provider of ePRO services
- Nearly doubled its space at both U.S. and European headquarters in Boston and Geneva to accommodate continued headcount growth, primarily in the Client Delivery Services Teams, in order to fulfill increased study workload
- Continued to make significant investments in its product suite including product line expansion
Excluding pass-throughs, PHT booked more in the first nine months of 2007 than in all of 2006, which was a record breaking year for not only PHT, but for the entire industry. PHT’s services bookings have grown by 30% year-over-year.
PHT President and CEO Phil Lee said, “This has been a tremendous year for PHT with sustained profitability, record bookings and headcount growth. Due to our robust technology and scientific expertise, PHT continues to separate itself as the clear market share leader in the expanding ePRO market. Our growth is driven by increased market adoption and PHT’s superior delivery services as more trial sponsors experience the dramatic improvements in data quality, trial management efficiencies, and patient safety our ePRO products provide.”
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 330 clinical trials around the world. PHT’s proven LogPad(R) and StudyPad(R) Systems deliver the voice of the patient – directly and without distortion – with reliable and timely self-reported data. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least nine NDA submissions, with five known approvals, to date. To learn more about how study sponsors worldwide are using ePRO to improve data quality, conduct smaller trials, and manage patient safety, enrollment and compliance in real time, visit the new www.phtcorp.com.
PHT, LogPad, StudyPad, StudyWorks and SimpleSend are among the registered trademarks and trademarks of PHT Corporation.
###
